Detection and quantification of protein adduction by electrophilic fatty acids: mitochondrial generation of fatty acid nitroalkene derivatives

  • F. J. Schopfer
  • C. Batthyany
  • P. R.S. Baker
  • G. Bonacci
  • M. P. Cole
  • V. Rudolph
  • A. L. Groeger
  • T. K. Rudolph
  • S. Nadtochiy
  • P. S. Brookes
  • B. A. Freeman

Beteiligte Einrichtungen

Abstract

Nitroalkene fatty acid derivatives manifest a strong electrophilic nature, are clinically detectable, and induce multiple transcriptionally regulated anti-inflammatory responses. At present, the characterization and quantification of endogenous electrophilic lipids are compromised by their Michael addition with protein and small-molecule nucleophilic targets. Herein, we report a trans-nitroalkylation reaction of nitro-fatty acids with β-mercaptoethanol (BME) and apply this reaction to the unbiased identification and quantification of reaction with nucleophilic targets. Trans-nitroalkylation yields are maximal at pH 7 to 8 and occur with physiological concentrations of target nucleophiles. This reaction is also amenable to sensitive mass spectrometry-based quantification of electrophilic fatty acid-protein adducts upon electrophoretic resolution of proteins. In-gel trans-nitroalkylation reactions also permit the identification of protein targets without the bias and lack of sensitivity of current proteomic approaches. Using this approach, it was observed that fatty acid nitroalkenes are rapidly metabolized in vivo by a nitroalkene reductase activity and mitochondrial β-oxidation, yielding a variety of electrophilic and nonelectrophilic products that could be structurally characterized upon BME-based trans-nitroalkylation reaction. This strategy was applied to the detection and quantification of fatty acid nitration in mitochondria in response to oxidative inflammatory conditions induced by myocardial ischemia-reoxygenation.

Bibliografische Daten

OriginalspracheEnglisch
ISSN0891-5849
DOIs
StatusVeröffentlicht - 01.05.2009

Anmerkungen des Dekanats

Funding Information:
This work was supported in part by National Institutes of Health Grants HL58115 and HL64937 (to B.A.F.), AHA 0665418U (to F.J.S.) and ADA 7-08-JF-52 (to F.J.S.), ADA 7-06-JF-06 (to P.R.S.B), P30 DK046204-15 and T32DK007052-34 (to M.C.P.), and the Deutsche Herzstiftung (to V.R. and T.K.R.). B.A.F. acknowledges a financial interest in Complexa, LLC. We thank Eric Kelley, Ph.D., and Bruce Branchaud, Ph.D., for helpful guidance.